Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Supplemental health/life specialist; ~75% of revenue from Japan (cancer + accident coverage); ~$19B 2024 revenue; the duck.
Aflac Japan's revenue by product line. Cancer insurance is the legacy flagship (Aflac introduced cancer insurance to Japan in 1974 and still has ~25%+ market share). Medical (hospitalization indemnity) is the modern growth product. Other Life includes WAYS and child endowment plans.
Total: 100 stores
Source: Aflac 2024 Annual Report — Japan segment product breakdown (Updated: 2025-02)
Aflac's revenue split — Japan is ~70-75% of group revenue (Aflac Japan: supplemental cancer, medical, life). US is the smaller (and slower-growing) worksite business focused on accident, short-term disability, dental/vision. The yen/dollar rate moves Japan reported USD heavily — 2022-2024 weak yen depressed reported numbers.
2020 — 2024
Source: Aflac 10-K segment notes — net earned premiums (FY 2020-2024) (Updated: 2025-02)
Quarterly breakdown of revenue by product line and service category
2021-Q2 — 2026-Q1
Quarterly breakdown of revenue by geographic region
2021-Q2 — 2026-Q1
Data from SEC filings via FMP • 62 periods available